| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
ARTICLES |
Department of Molecular Pharmacology and Biological Chemistry, Northwestern University Medical School, Chicago, Illinois 60611
Address all correspondence and requests for reprints to: Dr. Laurie G. Hudson, Department of Molecular Pharmacology and Biological Chemistry, Searle 8565, Northwestern University Medical School, 303 East Chicago Avenue, Chicago, Illinois 60611.
In keratinocytes, epidermal growth factor (EGF) promotes cell motility
in addition to proliferation. As EGF receptor expression is elevated
during wound healing and in many epithelial tumors, we wanted to
investigate whether there is a direct relationship between EGF receptor
expression and ligand-mediated cellular locomotion. EGF receptor
activation induced cell migration in normal keratinocytes and their
tumorigenic counterparts; however, the rate of colony dispersion and
in vitro reepithelialization was more rapid in the
squamous cell carcinoma (SCC) lines that exhibited elevated (
5-fold)
EGF receptor levels. Within a single SCC line, submaximal
concentrations of EGF or reduction of EGF receptor activity by an
anti-EGF receptor neutralizing antibody resulted in delayed kinetics of
in vitro reepithelialization. Thus, suppression of EGF
receptor activity in an overexpressing SCC line restores a migratory
response that more closely resembles that of normal keratinocytes.
Conversely, ligand-induced colony dispersion was augmented in stable
clonal cell lines in which EGF receptor expression was elevated after
introduction of an EGF receptor complementary DNA construct.
Collectively, these findings suggest that the migratory potential of
keratinocytes is modulated at the level of both receptor expression and
ligand concentration, with a positive correlation between EGF receptor
levels and ligand-induced cell motility.
This article has been cited by other articles:
![]() |
G. W. Neill, W. J. Harrison, M. S. Ikram, T. D.L. Williams, L. S. Bianchi, S. K. Nadendla, J. L. Green, L. Ghali, A.-M. Frischauf, E. A. O'Toole, et al. GLI1 repression of ERK activity correlates with colony formation and impaired migration in human epidermal keratinocytes Carcinogenesis, April 1, 2008; 29(4): 738 - 746. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Tokumaru, K. Sayama, Y. Shirakata, H. Komatsuzawa, K. Ouhara, Y. Hanakawa, Y. Yahata, X. Dai, M. Tohyama, H. Nagai, et al. Induction of Keratinocyte Migration via Transactivation of the Epidermal Growth Factor Receptor by the Antimicrobial Peptide LL-37 J. Immunol., October 1, 2005; 175(7): 4662 - 4668. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. D. Harms, G. M. Bassi, A. R. Horwitz, and D. A. Lauffenburger Directional Persistence of EGF-Induced Cell Migration Is Associated with Stabilization of Lamellipodial Protrusions Biophys. J., February 1, 2005; 88(2): 1479 - 1488. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. C. Kurten, P. Chowdhury, R. C. Sanders Jr., L. M. Pittman, L. W. Sessions, T. C. Chambers, C. S. Lyle, B. J. Schnackenberg, and S. M. Jones Coordinating epidermal growth factor-induced motility promotes efficient wound closure Am J Physiol Cell Physiol, January 1, 2005; 288(1): C109 - C121. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. Barnes, R. Bagheri-Yarmand, M. Mandal, Z. Yang, G. L. Clayman, W. K. Hong, and R. Kumar Suppression of Epidermal Growth Factor Receptor, Mitogen-activated Protein Kinase, and Pak1 Pathways and Invasiveness of Human Cutaneous Squamous Cancer Cells by the Tyrosine Kinase Inhibitor ZD1839 (Iressa) Mol. Cancer Ther., April 1, 2003; 2(4): 345 - 351. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Kari, T. O. Chan, M. Rocha de Quadros, and U. Rodeck Targeting the Epidermal Growth Factor Receptor in Cancer: Apoptosis Takes Center Stage Cancer Res., January 1, 2003; 63(1): 1 - 5. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. J. Kottke, A. L. Blajeski, L. M. Martins, P. W. Mesner Jr., N. E. Davidson, W. C. Earnshaw, D. K. Armstrong, and S. H. Kaufmann Comparison of Paclitaxel-, 5-Fluoro-2'-deoxyuridine-, and Epidermal Growth Factor (EGF)-induced Apoptosis. EVIDENCE FOR EGF-INDUCED ANOIKIS J. Biol. Chem., May 28, 1999; 274(22): 15927 - 15936. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. K. Pilcher, J. Dumin, M. J. Schwartz, B. A. Mast, G. S. Schultz, W. C. Parks, and H. G. Welgus Keratinocyte Collagenase-1 Expression Requires an Epidermal Growth Factor Receptor Autocrine Mechanism J. Biol. Chem., April 9, 1999; 274(15): 10372 - 10381. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Zhao, A. Dick, J. V. Forrester, and C. D. McCaig Electric Field-directed Cell Motility Involves Up-regulated Expression and Asymmetric Redistribution of the Epidermal Growth Factor Receptors and Is Enhanced by Fibronectin and Laminin Mol. Biol. Cell, April 1, 1999; 10(4): 1259 - 1276. [Abstract] [Full Text] |
||||
![]() |
L. J. McCawley, S. Li, E. V. Wattenberg, and L. G. Hudson Sustained Activation of the Mitogen-activated Protein Kinase Pathway. A MECHANISM UNDERLYING RECEPTOR TYROSINE KINASE SPECIFICITY FOR MATRIX METALLOPROTEINASE-9 INDUCTION AND CELL MIGRATION J. Biol. Chem., February 12, 1999; 274(7): 4347 - 4353. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Fang, E Ionides, G Oster, R Nuccitelli, and R. Isseroff Epidermal growth factor receptor relocalization and kinase activity are necessary for directional migration of keratinocytes in DC electric fields J. Cell Sci., January 6, 1999; 112(12): 1967 - 1978. [Abstract] [PDF] |
||||
![]() |
A. Malliri, M. Symons, R. F. Hennigan, A. F.L. Hurlstone, R. F. Lamb, T. Wheeler, and B. W. Ozanne The Transcription Factor AP-1 Is Required for EGF-induced Activation of Rho-like GTPases, Cytoskeletal Rearrangements, Motility, and In Vitro Invasion of A431 Cells J. Cell Biol., November 16, 1998; 143(4): 1087 - 1099. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-P. Pienimaki, K. Rilla, C. Fulop, R. K. Sironen, S. Karvinen, S. Pasonen, M. J. Lammi, R. Tammi, V. C. Hascall, and M. I. Tammi Epidermal Growth Factor Activates Hyaluronan Synthase 2 in Epidermal Keratinocytes and Increases Pericellular and Intracellular Hyaluronan J. Biol. Chem., June 1, 2001; 276(23): 20428 - 20435. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |